Yunoki Tatsuya, Tabuchi Yoshiaki, Kondo Takashi, Ishii Yoko, Hayashi Atsushi
Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Division of Molecular Genetics Research, Life Science Research Center, University of Toyama, Toyama 930-0194, Japan.
Oncol Lett. 2017 Jun;13(6):4169-4172. doi: 10.3892/ol.2017.5958. Epub 2017 Mar 30.
Bcl-2-associated athanogene 3 (BAG3), a co-chaperone of heat shock protein 70 (HSP70), exerts anti-apoptotic effects in various malignant tumors. However, relationships between choroidal melanoma and BAG3 are poorly studied. This study investigated the expression of BAG3 in a case of human choroidal melanoma. Funduscopy, computed tomography, and single-photon emission computed tomography with the intravenous injection of N-isopropyl-p-[I] iodoamphetamine strongly indicated choroidal melanoma in a 68-year-old woman. Accordingly, we carried out an enucleation and pathological diagnosis. Proteins and total RNA were extracted from normal retinochoroidal and tumor tissues. Proteins were also extracted from ocular nevus tissues of other patients. We examined the expression of BAG3 protein and mRNA using Western blotting and the real-time quantitative polymerase chain reaction, respectively. Immunohistochemical stains were positive for melan-A, HMB-45, and S-100. Histopathology confirmed a choroidal melanoma. The expression of BAG3 protein and mRNA in the choroidal melanoma tissue was upregulated with respect to both normal retinochoroidal tissue and ocular nevus tissues from other patients. Because BAG3 may inhibit apoptosis of choroidal melanoma and facilitate its survival, overexpression of this gene product may be a prognostic marker and therapeutic target.
Bcl-2相关抗凋亡基因3(BAG3)是热休克蛋白70(HSP70)的一种共伴侣蛋白,在多种恶性肿瘤中发挥抗凋亡作用。然而,脉络膜黑色素瘤与BAG3之间的关系研究较少。本研究调查了BAG3在1例人类脉络膜黑色素瘤中的表达情况。眼底镜检查、计算机断层扫描以及静脉注射N-异丙基-p-[I]碘安非他明后的单光子发射计算机断层扫描强烈提示一名68岁女性患有脉络膜黑色素瘤。因此,我们进行了眼球摘除及病理诊断。从正常视网膜脉络膜组织和肿瘤组织中提取蛋白质和总RNA。还从其他患者的眼痣组织中提取了蛋白质。我们分别使用蛋白质印迹法和实时定量聚合酶链反应检测BAG3蛋白和mRNA的表达。免疫组织化学染色显示黑色素A、HMB-45和S-100呈阳性。组织病理学证实为脉络膜黑色素瘤。与正常视网膜脉络膜组织和其他患者的眼痣组织相比,脉络膜黑色素瘤组织中BAG3蛋白和mRNA的表达上调。由于BAG3可能抑制脉络膜黑色素瘤的凋亡并促进其存活,该基因产物的过表达可能是一种预后标志物和治疗靶点。